CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.

• Príomhchruthaitheoirí: Tomoo Sato (Údar), Ariella Coler-Reilly (Údar), Atae Utsunomiya (Údar), Natsumi Araya (Údar), Naoko Yagishita (Údar), Hitoshi Ando (Údar), Junji Yamauchi (Údar), Eisuke Inoue (Údar), Takahiko Ueno (Údar), Yasuhiro Hasegawa (Údar), Kusuki Nishioka (Údar), Toshihiro Nakajima (Údar), Steven Jacobson (Údar), Shuji Izumo (Údar), Yoshihisa Yamano (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Public Library of Science (PLoS), 2013-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) -associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a rare chronic neuroinflammatory disease. Since the disease course of HAM/TSP varies among patients, there is a dire need for biomarkers capable of predicting the rate of disease p...